Why Australia is the Destination of Choice for International Medical Device Clinical Trials. Listen to our Virtual Medtech Conference 2020 Webinar!

To mark our involvement in the Virtual Medtech Conference 2020 in Toronto,  we hosted a special webinar with Austrade, for US and Canadian medical device companies who may benefit from running clinical trials in Australia. The session explored ‘Australia as a medical device trial destination: Maintain momentum in your clinical development program’, and focused on first-in-human / early phase cardiovascular medical device trials.  Discussions cover the clinical trials landscape in Australia and the impact of COVID-19 on maintaining research momentum, the opportunities for international collaboration and a German company’s firsthand experience as a multinational medical device company running clinical trial programs in Australia.  A special thanks to our stellar panel:Hon. Peter McGauran – Australia’s Consul General and Senior Trade & Investment Commissioner, Austrade HoustonDr Dan Grant – Managing Director & CEO MTPConnectProf John Kovacic – Executive Director Victor Chang Cardiac Research InstituteProf Gemma Figtree – President Australian Cardiovascular Alliance Mr Falko Thiele – Director Clinical & Regulatory Affairs BIOTRONIK Australia (HQ Germany)